On the Record · Alexion Pharmaceuticals
Alexion Pharmaceuticals competitors, on the record
The companies Alexion Pharmaceuticals itself names as competitors in its annual reports, 2018 to 2020, each with the sentence it appears in and the filing it came from.
Who Alexion Pharmaceuticals names
| Company | Named in |
|---|---|
| Generium | 2020 |
In its own words
Generium
Word for word“In addition, in 2019 a SOLIRIS biosimilar was introduced in Russia (which was sold by Generium) and we experienced a significant decrease in sales of SOLIRIS following the introduction of Generium’s biosimilar.” 10-K for 2020
Read from Alexion Pharmaceuticals’s annual reports (10-K for 2020, 10-K for 2019, 10-K for 2018) and the financial data it files with the SEC, as of 2021-02-08. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.